MedTrace Logo

The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients

NCT01948336 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-09-23

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of dexmedetomidine infusion on early stage renal function.

Conditions

  • Renal Function Disorder
  • Hemodynamic Instability

Interventions

DRUG

Dexmedetomidine

a loading dose of 1 µg kg-1 dexmedetomidine (Precedex Abbott Labs, North Chicago, IL) IV given over 10 minutes, followed by 0.5 µg kg-1 hour-1 IV dexmedetomidine infusion were administered. Dexmedetomidine was prepared as a 1 µg ml-1 solution using D5 0.3% NaCl solution.

DRUG

Ketamine

ketamine was bolused with 1 mg kg-1(IV) and followed by 1 mg kg-1 hour-1 ketamine IV infusion during the procedure.

DRUG

Propofol

propofol was bolused 1 mg kg-1 and 50 µg kg-1 min-1 propofol (IV) infusion during the procedure.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Adnan Bayram, Asst. Prof. · TC Erciyes University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
72 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-04-30
Completion
2013-08-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01948336 on ClinicalTrials.gov